bosentan anhydrous has been researched along with Eisenmenger Syndrome in 49 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 25 (51.02) | 29.6817 |
2010's | 23 (46.94) | 24.3611 |
2020's | 1 (2.04) | 2.80 |
Authors | Studies |
---|---|
Gorbachevsky, SV; Shmalts, AA | 1 |
Akbal, ÖY; Kaymaz, C; Öztürk, S; Poci, N; Tokgöz, HC | 1 |
AboElnas, MM; Elshafay, A; Hirayama, K; Huy, NT; Idrees, H; Metwali, HG; Saad, OA; Truong, DH; Vuong, NL | 1 |
Hartwig, BJ; Schultze, B | 1 |
Kuang, HY; Li, Q; Lu, TW; Wu, YH; Yi, QJ | 1 |
Crepaz, R; De Santis, S; Montanaro, D; Romeo, C | 1 |
Cam, H; Dag, MS; Davutoglu, V; Durmus, E; Kivrak, T; Sari, I; Tigen, K | 1 |
Hu, L; Tan, LH; Ye, J | 1 |
Abd El Rahman, MY; Abdul-Khaliq, H; Balling, G; Berger, F; Böttler, P; Dubowy, KO; Farahwaschy, B; Hager, A; Kreuder, J; Mebus, S; Miera, O; Peters, B; Rentzsch, A; Scherber, P; Schulze-Neick, I | 1 |
Başer, HD; Cengel, A; Taçoy, G; Türkoğlu, S | 1 |
Yao, A | 1 |
Bull, DA; Hatton, N; Ryan, JJ; Suksaranjit, P; Wilson, BD | 1 |
Berger, RM; Bouma, BJ; Duffels, MG; Hoendermis, ES; Mulder, BJ; van Dijk, AP; van Loon, RL; Vis, JC | 1 |
Book, WM; Lee, EK; Lyle, TA; McConnell, ME; Mehta, PK; Simpson, L | 1 |
Emoto, N; Hirata, K; Iwasa, N; Kato, H; Kawai, H; Kuroda, Y; Matsuo, N; Miyagawa, K; Ohnishi, T; Yoshida, A | 1 |
Beghetti, M; Galiè, N | 1 |
Dias, B; Fine, N; Mehta, S; Shoemaker, G | 1 |
Beghetti, M; Berger, RM; Chiossi, E; Galiè, N; Gatzoulis, MA; Granton, J; Landzberg, M; Lauer, A | 3 |
Díaz-Caraballo, E; García-Río, F; González-García, AE; Oliver-Ruiz, JM; Reñones, M; Sánchez-Recalde, A | 1 |
Agras, PI; Guveloglu, M; Hizli, S; Kabakus, N; Ozdemir, O | 1 |
Acar, P | 1 |
Iversen, K; Jensen, AS; Jensen, TV; Søndergaard, L; Vejlstrup, NG | 1 |
Białkowski, J | 1 |
Argiento, P; Calabrò, R; D'Alto, M; Gaio, G; Mélot, C; Naeije, R; Romeo, E; Russo, MG; Santoro, G; Sarubbi, B | 1 |
Argiento, P; Calabrò, R; Correra, A; D'Alto, M; Grimaldi, N; Romeo, E; Russo, MG; Santoro, G; Sarubbi, B; Scognamiglio, G | 1 |
Correale, M; D'Agostino, C; D'Amato, N; Di Biase, M | 1 |
Gatzoulis, MA | 1 |
Ayhan, S; Eren, M; Erer, B; Eryol, NK; Kaya, MG; Lam, YY; Meric, M; Nurkalem, Z; Vatankulu, MA | 1 |
Valente, AM | 1 |
Guzik, T; Kopeć, G; Mikołajczyk, T; Miszalski-Jamka, T; Podolec, P; Tyrka, A; Waligóra, M | 1 |
Daniels, CJ | 1 |
D'Alto, M; Mahadevan, VS | 1 |
Book, WM; Christensen, DD; Mahle, WT; McConnell, ME | 1 |
Beghetti, M; Friedli, B; Trindade, PT | 1 |
Cramer, D; Gatzoulis, MA; Gibbs, JS; Harries, C; Li, W; Mikhail, GW; Rogers, P; Ward, S | 1 |
Akhter, P; Bowen, M; McKenna, P; Molelekwa, V; Walsh, K | 1 |
Agapito, AF; Cacela, D; Feliciano, J; Oliveira, JA; Quininha, J; Sousa, L | 1 |
Celermajer, DS; Hayward, CS; Keogh, AM; Kermeen, F; Kotlyar, E; Macdonald, PS; McNeil, KD; Sy, R | 1 |
Brevière, GM; Duhamel, A; Francart, C; Godart, F; Poindron, D; Rey, C; Richard, A | 1 |
Christopoulos, A; Kourouklis, S; Kyriakides, ZS; Liagkas, K; Paradellis, G | 1 |
Argiento, P; Badagliacca, R; Calabrò, R; D'Alto, M; Fedele, F; Ferrante, F; Mancone, M; Poscia, R; Romeo, E; Russo, MG; Santoro, G; Sarubbi, B; Vizza, CD | 1 |
Brun, H; Fredriksen, PM; Holmstrom, H; Thaulow, E | 1 |
Blanco-Aparicio, M; Ferrer-Barba, A; Medrano-López, C; Otero-González, I; Raposo-Sonnenfeld, I | 1 |
Diller, GP; Dimopoulos, K; Gatzoulis, MA; Gibbs, JS; Harries, C; Kaya, MG; Koltsida, E; Li, W; Uebing, A | 1 |
Cornel, JH; Duffels, MG; Hamaker, ME; Mulder, BJ; Reichert, CL; Umans, VA | 1 |
Berger, RM; Duffels, MG; Hillege, HL; Hoendermis, ES; Mulder, BJ; van Loon, RL; Vonk-Noordegraaf, A | 1 |
Durongpisitkul, K; Jakrapanichakul, D; Sompradikul, S | 1 |
6 review(s) available for bosentan anhydrous and Eisenmenger Syndrome
Article | Year |
---|---|
The Effect of Endothelin Receptor Antagonists in Patients with Eisenmenger Syndrome: A Systematic Review.
Topics: Antihypertensive Agents; Blood Pressure; Bosentan; Clinical Trials as Topic; Eisenmenger Complex; Endothelin Receptor Antagonists; Humans; Quality of Life; Sildenafil Citrate; Sulfonamides; Vasodilator Agents | 2018 |
Review of evidence for bosentan therapy for treatment of Eisenmenger syndrome.
Topics: Antihypertensive Agents; Bosentan; Eisenmenger Complex; Endothelin Receptor Antagonists; Humans; Randomized Controlled Trials as Topic | 2019 |
What is the position of pulmonary arterial hypertension-specific drug therapy in patients with Eisenmenger syndrome: A systematic review and meta-analysis.
Topics: Antihypertensive Agents; Bosentan; Eisenmenger Complex; Endothelin Receptor Antagonists; Exercise Tolerance; Hemodynamics; Humans; Hypertension, Pulmonary; Oxygen; Phenylpropionates; Phosphodiesterase 5 Inhibitors; Prostaglandins; Pyridazines; Pyrimidines; Sulfonamides | 2019 |
Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension.
Topics: Antihypertensive Agents; Bosentan; Eisenmenger Complex; Endothelin Receptor Antagonists; Epoprostenol; Humans; Hypertension, Pulmonary; Isoxazoles; Phosphodiesterase Inhibitors; Piperazines; Pulmonary Circulation; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Thiophenes | 2009 |
Endothelin receptor antagonist therapy in congenital heart disease with shunt-associated pulmonary arterial hypertension: a qualitative systematic review.
Topics: Antihypertensive Agents; Bosentan; Eisenmenger Complex; Endothelin Receptor Antagonists; Exercise Test; Heart Defects, Congenital; Hemodynamics; Humans; Hypertension, Pulmonary; Pulmonary Circulation; Sulfonamides | 2009 |
Pulmonary arterial hypertension associated with congenital heart disease.
Topics: Antihypertensive Agents; Bosentan; Clinical Trials as Topic; Comorbidity; Down Syndrome; Eisenmenger Complex; Endothelium, Vascular; Epoprostenol; Health Behavior; Heart Defects, Congenital; Heart Transplantation; Humans; Hypertension, Pulmonary; Lung Transplantation; Oxygen Inhalation Therapy; Phosphodiesterase 5 Inhibitors; Piperazines; Practice Guidelines as Topic; Pulmonary Circulation; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Thrombosis | 2012 |
7 trial(s) available for bosentan anhydrous and Eisenmenger Syndrome
Article | Year |
---|---|
Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis.
Topics: Adult; Antihypertensive Agents; Bosentan; Boston; Canada; Double-Blind Method; Eisenmenger Complex; Exercise; Female; Heart Septal Defects, Atrial; Heart Septal Defects, Ventricular; Hemodynamics; Humans; Hypertension, Pulmonary; Italy; Male; Middle Aged; Netherlands; Ontario; Oximetry; Pulmonary Circulation; Pulmonary Wedge Pressure; Sulfonamides; Switzerland; Treatment Outcome; United Kingdom; Vascular Resistance | 2010 |
Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial.
Topics: Adult; Aged; Antihypertensive Agents; Bosentan; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Eisenmenger Complex; Female; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Treatment Outcome; Young Adult | 2010 |
Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.
Topics: Administration, Oral; Adult; Bosentan; Dose-Response Relationship, Drug; Drug Therapy, Combination; Eisenmenger Complex; Exercise Test; Familial Primary Pulmonary Hypertension; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Male; Piperazines; Prospective Studies; Pulmonary Wedge Pressure; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Time Factors; Treatment Outcome; Vascular Resistance | 2012 |
Long-term effect of bosentan therapy on cardiac function and symptomatic benefits in adult patients with Eisenmenger syndrome.
Topics: Adult; Antihypertensive Agents; Bosentan; Diastole; Dose-Response Relationship, Drug; Echocardiography, Doppler; Eisenmenger Complex; Female; Follow-Up Studies; Heart Ventricles; Humans; Male; Prospective Studies; Pulmonary Wedge Pressure; Sulfonamides; Systole; Time Factors; Treatment Outcome; Ventricular Function, Right | 2012 |
Changes in exercise capacity and cardiac performance in a series of patients with Eisenmenger's syndrome transitioned from selective to dual endothelin receptor antagonist.
Topics: Adult; Antihypertensive Agents; Bosentan; Eisenmenger Complex; Endothelin Receptor Antagonists; Endothelin-1; Exercise; Female; Follow-Up Studies; Humans; Isoxazoles; Magnetic Resonance Imaging; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Stroke Volume; Sulfonamides; Thiophenes | 2012 |
Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study.
Topics: Adult; Antihypertensive Agents; Bosentan; Double-Blind Method; Eisenmenger Complex; Endothelin Receptor Antagonists; Exercise Tolerance; Female; Hemodynamics; Humans; Male; Middle Aged; Oxygen; Sulfonamides; Treatment Outcome | 2006 |
Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study.
Topics: Adult; Aged; Antihypertensive Agents; Bosentan; Double-Blind Method; Drug Administration Schedule; Eisenmenger Complex; Exercise Tolerance; Female; Humans; Male; Middle Aged; Sulfonamides; Treatment Outcome; Vascular Resistance | 2008 |
36 other study(ies) available for bosentan anhydrous and Eisenmenger Syndrome
Article | Year |
---|---|
[Evidence base for specific pulmonary vasodilators in adults with congenital heart disease].
Topics: Adult; Antihypertensive Agents; Bosentan; Eisenmenger Complex; Endothelin Receptor Antagonists; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Phosphodiesterase 5 Inhibitors; Prostaglandins; Pulmonary Arterial Hypertension; Randomized Controlled Trials as Topic; Vasodilator Agents | 2021 |
A successful cesarean delivery without fetal or maternal morbidity in an Eisenmenger patient with cor triatriatum sinistrum, double-orifice mitral valve, large ventricular septal defect, and single ventricle who was under long-term bosentan treatment.
Topics: Adult; Bosentan; Cardiovascular Agents; Cesarean Section; Cor Triatriatum; Eisenmenger Complex; Female; Heart Septal Defects, Ventricular; Humans; Infant, Extremely Premature; Infant, Newborn; Sulfonamides | 2017 |
Long-term results of treatment with bosentan in adult Eisenmenger's syndrome patients with Down's syndrome related to congenital heart disease.
Topics: Adolescent; Adult; Antihypertensive Agents; Bosentan; Down Syndrome; Eisenmenger Complex; Exercise Test; Female; Follow-Up Studies; Heart Defects, Congenital; Humans; Male; Retrospective Studies; Sulfonamides; Time Factors; Treatment Outcome; Young Adult | 2013 |
Recurrent gastrointestinal bleeding in a patient with Eisenmenger syndrome using bosentan.
Topics: Antihypertensive Agents; Bosentan; Eisenmenger Complex; Familial Primary Pulmonary Hypertension; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Pulmonary; Recurrence; Sulfonamides; Young Adult | 2013 |
Repair of ventricular septal defect with Eisenmenger syndrome after bosentan treatment.
Topics: Antihypertensive Agents; Bosentan; Cardiac Surgical Procedures; Child; Eisenmenger Complex; Female; Heart Septal Defects, Ventricular; Heart Septum; Humans; Hypertension, Pulmonary; Sulfonamides; Time Factors; Treatment Outcome; Vascular Resistance | 2014 |
Effect of bosentan therapy on ventricular and atrial function in adults with Eisenmenger syndrome. A prospective, multicenter study using conventional and Speckle tracking echocardiography.
Topics: Adult; Antihypertensive Agents; Atrial Function; Bosentan; Cardiac Catheterization; Echocardiography; Eisenmenger Complex; Exercise Test; Female; Humans; Male; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Sulfonamides; Vascular Resistance; Ventricular Function; Young Adult | 2014 |
[The management of adult female patients with Eisenmenger syndrome and advanced pulmonary arterial hypertension treatment: single center experience and follow-up for 5 years].
Topics: Adult; Antihypertensive Agents; Bosentan; Echocardiography; Eisenmenger Complex; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Iloprost; Laser-Doppler Flowmetry; Piperazines; Pulmonary Wedge Pressure; Purines; Severity of Illness Index; Sildenafil Citrate; Sulfonamides; Treatment Outcome; Turkey | 2014 |
Medical treatment for an adult patient with eisenmenger syndrome. A case report.
Topics: Adult; Antihypertensive Agents; Bosentan; Down Syndrome; Eisenmenger Complex; Endothelin Receptor Antagonists; Heart Septal Defects, Ventricular; Humans; Hypertension, Pulmonary; Male; Phenylpropionates; Pyridazines; Sulfonamides | 2015 |
Eisenmenger syndrome with unrepaired patent ductus arteriosus.
Topics: Blood Transfusion; Bosentan; Diagnostic Imaging; Dobutamine; Ductus Arteriosus, Patent; Eisenmenger Complex; Epoprostenol; Female; Humans; Hypertension, Pulmonary; Magnetic Resonance Imaging; Menorrhagia; Piperazines; Purines; Sildenafil Citrate; Sulfonamides; Tomography, X-Ray Computed; Vasodilator Agents; Young Adult | 2015 |
Down patients with Eisenmenger syndrome: is bosentan treatment an option?
Topics: Adult; Bosentan; Down Syndrome; Eisenmenger Complex; Female; Follow-Up Studies; Humans; Male; Middle Aged; Sulfonamides; Treatment Outcome; Young Adult | 2009 |
Endothelin receptor antagonists improve exercise tolerance and oxygen saturations in patients with Eisenmenger syndrome and congenital heart defects.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Bosentan; Dose-Response Relationship, Drug; Drug Administration Schedule; Eisenmenger Complex; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Exercise Test; Female; Heart Defects, Congenital; Humans; Isoxazoles; Male; Middle Aged; Oxygen; Retrospective Studies; Sulfonamides; Thiophenes | 2008 |
[Remarkable response of bosentan, an endothelin receptor antagonist, for a patient with Eisenmenger syndrome].
Topics: Aged; Bosentan; Eisenmenger Complex; Endothelin Receptor Antagonists; Female; Heart Failure; Heart Septal Defects, Atrial; Humans; Hypertension, Pulmonary; Sulfonamides; Treatment Outcome | 2008 |
Long-term bosentan treatment of complex congenital heart disease and Eisenmenger's syndrome.
Topics: Adult; Bosentan; Eisenmenger Complex; Endothelin Receptor Antagonists; Female; Heart Diseases; Humans; Male; Sulfonamides; Time Factors | 2009 |
Eisenmenger syndrome and juvenile rheumatoid arthritis--a case of double diagnosis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Arthritis, Juvenile; Bosentan; Child; Diagnosis, Differential; Eisenmenger Complex; Female; Humans; Naproxen; Sulfonamides; Treatment Outcome | 2009 |
[Eisenmenger syndrome. Specific treatments].
Topics: Adult; Antihypertensive Agents; Bosentan; Eisenmenger Complex; Endothelin Receptor Antagonists; Epoprostenol; Female; Humans; Hypertension, Pulmonary; Life Expectancy; Male; Multicenter Studies as Topic; Palliative Care; Phosphodiesterase Inhibitors; Randomized Controlled Trials as Topic; Sulfonamides | 2009 |
[Bosenten and sildenafil in the treatment of Eisenmenger syndrome].
Topics: Adolescent; Antihypertensive Agents; Bosentan; Child; Eisenmenger Complex; Endothelin A Receptor Antagonists; Exercise Test; Humans; Hypertension; Piperazines; Purines; Sildenafil Citrate; Sulfonamides; Sulfones | 2010 |
Pulmonary vasoreactivity predicts long-term outcome in patients with Eisenmenger syndrome receiving bosentan therapy.
Topics: Adult; Antihypertensive Agents; Bosentan; Cardiac Catheterization; Eisenmenger Complex; Epidemiologic Methods; Epoprostenol; Exercise Tolerance; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle Aged; Prognosis; Pulmonary Artery; Sulfonamides; Treatment Outcome; Vascular Resistance; Young Adult | 2010 |
Eisenmenger's syndrome in pregnancy.
Topics: Adult; Bosentan; Echocardiography, Doppler; Echocardiography, Transesophageal; Eisenmenger Complex; Female; Hemodynamics; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Pulmonary Circulation; Sulfonamides; Treatment Outcome; Vasodilator Agents | 2013 |
The management of Eisenmenger syndrome in the modern treatment era: a case report.
Topics: Adult; Antihypertensive Agents; Bosentan; Combined Modality Therapy; Drug Therapy, Combination; Eisenmenger Complex; Exercise Tolerance; Familial Primary Pulmonary Hypertension; Female; Heart Septal Defects, Ventricular; Humans; Hypertension, Pulmonary; Iron, Dietary; Piperazines; Purines; Quality of Life; Sildenafil Citrate; Sulfonamides; Sulfones; Treatment Outcome; Vasodilator Agents | 2011 |
Advanced pulmonary vascular therapy for adults with congenital heart disease: potential for progress.
Topics: Bosentan; Eisenmenger Complex; Female; Humans; Male; Sulfonamides; Ventricular Function, Right | 2012 |
Adult congenital heart disease and pulmonary hypertension: management of a complex case.
Topics: Adult; Antihypertensive Agents; Bosentan; Cardiac Catheterization; Disease Progression; Dyspnea; Eisenmenger Complex; Exercise Test; Follow-Up Studies; Heart Septal Defects, Ventricular; Humans; Hypertension, Pulmonary; Oxygen; Pulmonary Valve Stenosis; Sulfonamides | 2012 |
Initial experience with bosentan therapy in patients with the Eisenmenger syndrome.
Topics: Adult; Aged; Antihypertensive Agents; Bosentan; Eisenmenger Complex; Endothelin-1; Female; Humans; Male; Middle Aged; Retrospective Studies; Sulfonamides | 2004 |
Initial experience with Bosentan therapy in patients with the Eisenmenger syndrome: Tetralogy of Fallot?
Topics: Antihypertensive Agents; Bosentan; Eisenmenger Complex; Endothelin-1; Humans; Sulfonamides; Tetralogy of Fallot | 2005 |
Safety and tolerability of bosentan in adults with Eisenmenger physiology.
Topics: Adult; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Bosentan; Eisenmenger Complex; Exercise Tolerance; Female; Forced Expiratory Volume; Heart Rate; Humans; London; Male; Middle Aged; Oxygen Consumption; Pilot Projects; Pulmonary Circulation; Sulfonamides; Systole; Treatment Outcome; Ventricular Function, Right; Vital Capacity | 2005 |
Eisenmenger's syndrome in a 27 week pregnancy--management with bosentan and sildenafil.
Topics: Adult; Antihypertensive Agents; Bosentan; Cesarean Section; Eisenmenger Complex; Female; Humans; Piperazines; Postoperative Care; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Prenatal Care; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Vasodilator Agents | 2005 |
Eisenmenger syndrome in the adult--experience with new drugs for the treatment of pulmonary hypertension.
Topics: Adult; Antihypertensive Agents; Bosentan; Eisenmenger Complex; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Iloprost; Male; Middle Aged; Retrospective Studies; Sulfonamides; Vasodilator Agents | 2005 |
Bosentan for the treatment of pulmonary arterial hypertension associated with congenital cardiac disease.
Topics: Adult; Antihypertensive Agents; Bosentan; Eisenmenger Complex; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Male; Pulmonary Wedge Pressure; Retrospective Studies; Sulfonamides; Treatment Outcome | 2006 |
[The effect of an endothelin receptor antagonist in Eisenmenger syndrome: a single-center experience of 11 patients].
Topics: Adolescent; Adult; Antihypertensive Agents; Bosentan; Eisenmenger Complex; Endothelin Receptor Antagonists; Exercise Tolerance; Female; Humans; Male; Middle Aged; Pulmonary Wedge Pressure; Retrospective Studies; Severity of Illness Index; Sulfonamides; Treatment Outcome; Walking | 2006 |
Bosentan in Eisenmenger syndrome and chronic thromboembolic pulmonary hypertension.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Bosentan; Chronic Disease; Down Syndrome; Echocardiography, Doppler; Eisenmenger Complex; Endothelin Receptor Antagonists; Female; Humans; Male; Middle Aged; Pulmonary Embolism; Sulfonamides; Treatment Outcome | 2006 |
Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical, and haemodynamic effect.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Bosentan; Dose-Response Relationship, Drug; Eisenmenger Complex; Exercise Tolerance; Female; Heart Rate; Humans; Hypertension, Pulmonary; Long-Term Care; Male; Oxygen Consumption; Prospective Studies; Sulfonamides; Treatment Outcome; Vascular Resistance | 2007 |
Treatment of patients with Eisenmenger's syndrome with Bosentan.
Topics: Adolescent; Antihypertensive Agents; Bosentan; Child; Child, Preschool; Eisenmenger Complex; Exercise Test; Female; Humans; Male; Oximetry; Prospective Studies; Sulfonamides; Treatment Outcome | 2007 |
[Treatment with sildenafil, bosentan, or both in children and young people with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome].
Topics: Adolescent; Adult; Antihypertensive Agents; Bosentan; Child; Eisenmenger Complex; Female; Humans; Hypertension, Pulmonary; Infant; Male; Piperazines; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Vasodilator Agents | 2007 |
Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease.
Topics: Adult; Aged; Antihypertensive Agents; Bosentan; Eisenmenger Complex; Exercise Tolerance; Follow-Up Studies; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Middle Aged; Oxygen; Safety; Sulfonamides | 2007 |
[Two patients with Eisenmenger syndrome treated with novel agents that target vasodilation of the pulmonary capillary bed].
Topics: Bosentan; Diuretics; Eisenmenger Complex; Female; Humans; Middle Aged; Oxygen Inhalation Therapy; Piperazines; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Vasodilation; Vasodilator Agents | 2007 |
Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?
Topics: Adolescent; Adult; Antihypertensive Agents; Bosentan; Child; Child, Preschool; Eisenmenger Complex; Exercise Tolerance; Female; Follow-Up Studies; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Male; Middle Aged; Pulmonary Wedge Pressure; Sulfonamides; Time Factors; Treatment Outcome; Vascular Resistance | 2007 |
A retrospective study of bosentan in pulmonary arterial hypertension associated with congenital heart disease.
Topics: Adolescent; Adult; Antihypertensive Agents; Bosentan; Databases as Topic; Eisenmenger Complex; Endothelins; Exercise Test; Female; Health Status; Health Status Indicators; Heart Defects, Congenital; Heart Ventricles; Humans; Hypertension, Pulmonary; Male; Middle Aged; Pulmonary Artery; Retrospective Studies; Sulfonamides; Systole; Time Factors; Treatment Outcome | 2008 |